COGNIFIRM ApS: Financial statements 2021
CVR: 41722932
Source: annual report 2021, Danish Business Authority
01/10/2020 – 30/09/2021
COGNIFIRM ApS (CVR 41722932) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -37,270 and a net result of DKK -30,155. Equity in the 2021 report amounted to DKK 9,845. The solvency ratio was 1.2%.
- Gross Profit
- DKK -37,270
- Profit/Loss
- DKK -30,155
- Equity
- DKK 9,845
- Total Assets
- DKK 834,066
Official annual report
Find more companies like COGNIFIRM ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of March 18, 2021, Lars Barthold Nielsen is registered as director of COGNIFIRM ApS.
As of March 18, 2021, Per Damgaard Husted is registered as adm. dir. of COGNIFIRM ApS.
As of March 18, 2021, Per Tversted has stepped down as adm. dir. of COGNIFIRM ApS.
As of March 18, 2021, Ramesh Packirisamy has stepped down as director of COGNIFIRM ApS.
As of March 17, 2021, Per Damgaard Husted has stepped down as director of COGNIFIRM ApS.
About COGNIFIRM ApS
COGNIFIRM ApS was a Danish company of the type Anpartsselskab based in Virum, founded in 2020. The company has been dissolved on 16 December 2024. The company was registered under the industry Computerprogrammering. In 2022, the company reported revenue of DKK 199,000 and a net result of DKK -537,172 compared with DKK -30,155 the year before. Equity in the 2022 report amounted to DKK -370,140.